Resistance to Immunotherapy and brain metastases … new approaches under development @myESMO
#ESMO26
#immunotherapy
#ESMO26
#immunotherapy
Can VEGF-directed immune strategies reshape treatment in hard-to-treat settings? At #ESMO26 Alessandra Curioni-Fontecedro (@MdCurioni) discusses pumitamig in brain metastases from SCLC and TNBC, IBI363 plus bevacizumab in IO-resistant lung adenocarcinoma, and the evidence still needed for routine useView quoted post on X
#ESMO26 @myESMO #LungCancer #Immunotherapy